<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In another clinical pilot trial, the effects of an essential oil blend of 
 <italic class="italic">Lavandula angustifolia</italic> Mill. and 
 <italic class="italic">Rose otto</italic> (syn. 
 <italic class="italic">Rosa</italic> Ã— 
 <italic class="italic">damascena</italic> Mill.), Rosaceae, in 28 postpartum women diagnosed with mild to moderate depression or anxiety [
 <xref rid="B30-molecules-22-01290" ref-type="bibr" class="xref">30</xref>]. The essential oil was administered by inhalation or using the dermal route (in a white lotion). Treatment consisted of 15 min sessions, twice a week for four consecutive weeks. The essential oils significantly relieved both depression symptoms (as scored by Edinburgh Postnatal Depression Scale (EPDS)), and anxiety (as scored by Generalized Anxiety Disorder Scale (GAD-7)). There were no adverse effects reported [
 <xref rid="B30-molecules-22-01290" ref-type="bibr" class="xref">30</xref>]. The study supported the beneficial effects of essential oils, in this case a combination of rose and lavender oils, for relief of depression and anxiety in postpartum women. Ultimately, this clinical study proposed an interesting approach combining distinct essential oils to better treat psychiatric disorders and/or comorbid diseases.
</p>
